F19.980
Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder
Clinical Classification Guidelines
Inclusion Terms
- Other (or unknown) substance-induced anxiety disorder, without use disorder
Medical Intelligence & Overview
ICD-10 code F19.980 refers to cases where an individual has used unspecified psychoactive substances leading to an anxiety disorder caused by that substance. This diagnosis is used when the specific type of substance is not identified or specified, but there is clear evidence that substance use has triggered an anxiety-related condition. Unlike substance use disorders characterized by dependency or addiction, this classification focuses specifically on anxiety symptoms that are directly linked to psychoactive substance intake, without necessarily indicating a broader substance use disorder. Recognizing this connection is crucial for appropriate management and treatment planning.
Causes & Symptoms
Clinical Causes: Use of psychoactive substances such as certain medications, recreational drugs, or chemicals that affect brain chemistry. Unintentional or accidental ingestion of substances with psychoactive effects. Situations where the specific substance is unknown or unspecified, but symptoms suggest substance-induced anxiety. Situations involving subthreshold or mild substance use that triggers anxiety symptoms without forming a formal substance use disorder. Concurrent stressful circumstances or mental health conditions that may amplify the anxiety response to substance use.
Key Symptoms: Persistent feelings of worry or fear Panic attacks with rapid heartbeat, sweating, trembling, or shortness of breath Restlessness or feeling on edge Muscle tension or aches Sleep disturbances such as difficulty falling or staying asleep Difficulty concentrating or feeling mentally foggy Physical symptoms like nausea, dizziness, or gastrointestinal distress Episodes of intense anxiety that may resemble panic attacks Worsening symptoms during or immediately after substance use
Diagnostic & Treatment
Diagnosis Path: Diagnosis of this condition involves a comprehensive clinical assessment, including a detailed history of substance use and symptom timeline. Clinicians look for evidence that symptoms of anxiety are directly associated with recent use of psychoactive substances, without evidence of a primary anxiety disorder or other mental health conditions. Laboratory tests or toxicology screens may assist in identifying the substances involved. Mental health evaluation helps rule out other causes of anxiety and confirms the temporal relationship between substance intake and symptom development.
Treatment Protocols: The general approach to managing psychoactive substance-induced anxiety involves addressing both the symptoms and the underlying substance use. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is F19.980 a billable ICD-10 code?
Yes, F19.980 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.980?
Clinical documentation must specify the nature of Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference